��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Treatment Effect of IFN-beta Is Restored after Disappearance of Neutralizing Antibodies

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 153

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Per Solberg Sorensen, MD, PhD, FAAN (Rigshospitalet Glostrup)	Dr. Sorensen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sorensen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA.
Peter Novak, MD (Brigham and Women'S Faulkner, Neurology)	Dr. Novak has received personal compensation for serving as an employee of Dysimmune Disease Foundation. Dr. Novak has stock in Pfeizer. Dr. Novak has stock in Moderna. Dr. Novak has stock in Novavax. Dr. Novak has stock in Editas Medicine. Dr. Novak has stock in Prothena. Dr. Novak has received publishing royalties from a publication relating to health care.
Nils Koch-Henriksen, MD (Dept of Neurology, Aalborg Hospital)	Dr. Koch-Henriksen has nothing to disclose.
	No disclosure on file
	No disclosure on file